Sale!

XRCC3 Gene Breast Cancer Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The XRCC3 gene plays a crucial role in the DNA repair mechanism, specifically in the homologous recombination repair of double-stranded breaks. Variants or mutations in the XRCC3 gene have been associated with an increased susceptibility to breast cancer, making it a significant marker for assessing genetic risk.

At DNA Labs UAE, individuals can undergo a genetic test specifically designed to analyze the XRCC3 gene for mutations that may increase their risk of developing breast cancer. This test is particularly recommended for those with a family history of breast cancer or other related cancers, as it provides valuable insights into their genetic predisposition.

The cost of the XRCC3 gene breast cancer susceptibility test at DNA Labs UAE is 4400 AED. The test involves a simple procedure, typically requiring a blood sample or cheek swab from the individual. After the sample is collected, it is analyzed in the laboratory using advanced genetic sequencing technologies to detect any mutations in the XRCC3 gene.

Receiving a comprehensive analysis of the XRCC3 gene can empower individuals with crucial information regarding their breast cancer risk, enabling them to make informed decisions about their health management and preventive measures. It is an essential tool in the realm of personalized medicine and cancer prevention strategies.

Description

XRCC3 Gene Breast Cancer Susceptibility to Genetic Test

Test Name: XRCC3 Gene Breast cancer susceptibility to Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cancer

Doctor: Oncologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for XRCC3 Gene Breast cancer, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XRCC3 Gene Breast cancer, susceptibility to NGS Genetic DNA Test gene XRCC3

Test Details: The XRCC3 gene, also known as X-ray repair cross-complementing protein 3, is involved in DNA repair processes. Variations or mutations in this gene have been associated with an increased susceptibility to breast cancer. NGS (Next-Generation Sequencing) is a type of genetic test that can analyze multiple genes simultaneously. It allows for the detection of various genetic variations or mutations, including those in the XRCC3 gene, that may be associated with an increased risk of breast cancer. By analyzing the XRCC3 gene and other relevant genes, NGS can provide a comprehensive assessment of an individual’s genetic predisposition to breast cancer. This information can be used to identify individuals at a higher risk and potentially guide personalized prevention or screening strategies. It’s important to note that genetic testing for breast cancer susceptibility should be done in consultation with a healthcare professional or genetic counselor. They can help interpret the results and provide appropriate guidance based on an individual’s personal and family history.

Test Name	XRCC3 Gene Breast cancer susceptibility to Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Cancer
Doctor	Oncologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for XRCC3 Gene Breast cancer, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with XRCC3 Gene Breast cancer, susceptibility to NGS Genetic DNA Test gene XRCC3
Test Details	The XRCC3 gene, also known as X-ray repair cross-complementing protein 3, is involved in DNA repair processes. Variations or mutations in this gene have been associated with an increased susceptibility to breast cancer. NGS (Next-Generation Sequencing) is a type of genetic test that can analyze multiple genes simultaneously. It allows for the detection of various genetic variations or mutations, including those in the XRCC3 gene, that may be associated with an increased risk of breast cancer. By analyzing the XRCC3 gene and other relevant genes, NGS can provide a comprehensive assessment of an individual’s genetic predisposition to breast cancer. This information can be used to identify individuals at a higher risk and potentially guide personalized prevention or screening strategies. It’s important to note that genetic testing for breast cancer susceptibility should be done in consultation with a healthcare professional or genetic counselor. They can help interpret the results and provide appropriate guidance based on an individual’s personal and family history.